FDA NDC Directory · JSON-LD · Markdown

Enoxaparin Sodium

NDC 63323-564 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078990
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsENOXAPARIN SODIUM (40 mg/.4mL)
Marketing started20190423
Package count1

External sources

Source: openFDA. Public-domain (CC0).